Stryker | SYK - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Abbott USD 5.86B 675M 2026-03
AtriCure USD 109.31M 3.97M 2026-03
Avanos Medical USD 94.2M 8.2M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
CONMED USD 183.45M 34.84M 2026-03
Cooper Companies USD 735.4M 40.2M 2026-03
Danaher USD 3.59B 375M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Medtronic USD 6.01B 595M 2026-03
Merit Medical Systems USD 184.8M 10.56M 2026-03
Olympus JPY 192.76B 27.86B 2026-03
Smith & Nephew USD 2.09B 117M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Terumo JPY 149.02B 4.17B 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12